Werbung
Literatur
1.
Taylor W, Diers Caviness M. eds. A Textbook for the Clinical Application of Therapuetic
Drug Monitoring. Irving, TX: Abbott Laboratories, Diagnostics Division; 1986:291-4.
2.
Dasgupta A, Dean R, Saldana S, et al. Absorption of therapeutic drugs by barrier gels in
serum separator blood collection tubes. Volume- and time-dependent reduction in total
and free drug concentrations. Am J Clin Pathol. 1994;101(4):456-61.
3.
Bakerman S. Bakerman's ABC's of Interpretive Laboratory Data, 4th ed. Scottsdale, AZ;
Interpretative Laboratory Data; 2002:259.
4.
Glew RH, Pavuk RA. Stability of gentamicin, tobramycin, and amikacin in combination with
four B-lactam antibiotics. Antimicrob Agents Chemother. 1983;24(4):474-77.
5.
Tindula RJ, Ambrose PJ, Harralson AF. Aminoglycoside inactivation by penicillins
and cephalosporins and its impact on drug-level monitoring. Drug Intell clin Pharm
1983;17:906-8.
6.
Pickering LK, Rutherford I. Effect of concentration and time upon inactivation of
tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam,
mezlocillin and pipercillin. J Pharmocol Exp Ther 1981;217:345-9.
7.
Pickering LK, Gearhart P. Effect of time and concentration upon interaction between
gentamicin, tobramycin, netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob
Agents Chemother 1979;15(4):592-6.
8.
Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia,
PA: WB Saunders; 1994:1134.
9.
Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia,
PA: WB Saunders; 1994:2214.
10. Tholen DW Kroll M, Astles JR, et al. Evaluation of the linearity of Quantitative Measurement
Procedures: A Statistical Approach; Approved Guideline (EP6-A). Wayne, PA: The National
Committee for Clinical Laboratory Standards, 2003.
11. Krouwer JS, Tholen DW Garber CC, et al. Method Comparison and Bias Estimation Using
Patient Samples; Approved Guideline-Second Edition (EP9-A2). Wayne, PA: The National
Committee for Clinical Laboratory Standards, 2002.
12. Passing H. Bablok W. A new biometrical procedure for testing the equality of
measurements from two different analytical methods. Application of linear regression
procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin
Biochem. 1983;21(11):709-20.
13. Bablok W. Passing H Bender R, et al. A general regression procedure for method
transformation. Application of linear regression procedures for method comparison
studies in clinical chemistry, Part III. J Clin Chem Clin Biochem. 1988;26(11):783-90.
14. Tholen DW, Kallner A, Kennedy JW, et al. Evaluation of Precision Performance of
Quantitative Measurement Methods; Approved Guideline - Second Edition (EP5-A2).
Wayne, PA: The National Committee for Clinical Laboratory Standards, 2004.
15. McEnroe RJ, Burritt MF, Powers DM, et al. Interference Testing in Clinical Chemistry;
Approved Guideline-Second Edition (EP7-A2). Wayne, PA: The National Committee for
Clinical Laboratory Standards, 2005.
Microgenics Corporation
46500 Kato Road
Fremont, CA 94538 USA
Kundenbetreuung und
technischer Support in den USA:
1-800-232-3342
Aktualisierungen der Packungsbeilage finden Sie auf:
www.thermoscientific.com/diagnostics
Weitere Länder:
Bitte wenden Sie sich an die Thermo Fisher Scientific-Vertretung in Ihrer Region.
© 2015 Thermo Fisher Scientific Inc. Alle Rechte vorbehalten.
Alle Marken sind Eigentum von Thermo Fisher Scientific und ihren Tochtergesellschaften.
0155976-H-DE
2015 09
4
Microgenics GmbH
Spitalhofstraße 94
D-94032 Passau, Deutschland
Tel: +49 (0) 851 886 89 0
Fax: +49 (0) 851 886 89 10
Werbung
